Please assess the completion status of the following clinical trial:

Trial Title: Impact of Aripiprazole on Postoperative Analgesia in Laparoscopic Hysterectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Physical status American Society of Anesthesiologist (ASA) I or II~* Electively scheduled for laparoscopic hysterectomy,~Exclusion Criteria:~* Patients who refuse to participate~* Body mass index (BMI) \> 30~* ASA physical status \> II~* Diabetes~* Major illnesses (e.g., cardiac, respiratory, renal, hepatic or neurological)~* Coagulation abnormalities~* Pregnancy~* Known hypersensitivity to aripiprazole or contraindications to its use (a psychiatric illness, patients on antidepressants, dementia-related psychosis)~* History of drug addiction or alcohol abuse~* Mental retardation interfering with the evaluation of pain scores or PCA programs .

- Gender: FEMALE
- Minimum Age: 40 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Aripiprazole (Type: ACTIVE_COMPARATOR): Patients will receive Aripiprazole 30 mg tablet orally 3 h before surgery
- Placebo (Type: PLACEBO_COMPARATOR): Patients will receive placebo tablet which is identical in appearance, size, shape, and color to aripiprazole 3 h before surgery.

Based on this trial design, predict the completion outcome and termination type (if applicable).